EUVIMEDEUVIMED entdecken
Metaanalyse

Influenza Vaccination and Cardiovascular Events in Patients with Ischaemic Heart Disease and Heart Failure: A Meta-Analysis

Daniel Modin, Mats Christian Højbjerg Lassen, Brian Claggett, Niklas Dyrby Johansen, Maryam Keshtkar-Jahromi, Kristoffer Grundtvig Skaarup, Joshua Nealon, Jacob A Udell, Orly Vardeny, Scott D Solomon, Gunnar Gislason, Tor Biering-Sørensen

European Journal of Heart Failure · 01.09.2023 · 25 (9) · 1685-1692

DOI: 10.1002/ejhf.2945 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Journal of Heart Failure, online erschienen am 05.07.2023. Verfasst von Daniel Modin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Heart Failure, Influenza, Human, Myocardial Ischemia, Coronary Artery Disease. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Randomized controlled trials (RCTs) enrolling patients at high cardiovascular risk have found that influenza vaccination may reduce the incidence of cardiovascular events. We performed an updated meta-analysis assessing the effect of influenza vaccination on the incidence of cardiovascular events in patients with ischaemic heart disease or heart failure. Methods and results We searched PubMed, EMBASE and other sources to identify RCTs examining the effect of influenza vaccination on the incidence of cardiovascular events assessed as efficacy outcomes in patients with ischaemic heart disease or heart failure. Eligible studies followed patients for at least one influenza season, defined as a minimum duration of 6 months. The primary endpoint was a composite of cardiovascular death, acute coronary syndrome, stent thrombosis or coronary revascularization, stroke or heart failure hospitalization. The secondary endpoints were cardiovascular death and all-cause death. Two investigators independently identified and extracted data from studies. Results were compared using hazard ratios (HRs) in both random effects and fixed effects models. We included five peer-reviewed and one non peer-reviewed RCTs for a total of 9340 patients. Five trials included patients with ischaemic heart disease (n = 4211) and one trial included patients with heart failure (n = 5129). Influenza vaccination was associated with a reduced incidence of the primary composite endpoint (random effects HR [rHR] 0.74, 95% confidence interval [CI] 0.63–0.88, p < 0.001, I2 = 52%), cardiovascular death (rHR 0.63, 95% CI 0.42–0.95, p = 0.028, I2 = 58%) and all-cause death (rHR 0.72, 95% CI 0.54–0.95, p = 0.0227, I2 = 52%). Results were similar when non peer-reviewed data were excluded.

Conclusion

In this meta-analysis of available RCTs in patients at high cardiovascular risk, influenza vaccination was associated with a reduced incidence of cardiovascular events, cardiovascular death and all-cause death as compared to placebo or no treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureInfluenza, HumanMyocardial IschemiaCoronary Artery DiseaseCardiovascular DiseasesHumansVaccination

Stichwörter der Autor:innen

Acute myocardial infarctionHeart failureInfluenza vaccineIschaemic heart diseaseMeta-analysisTrial

Autor:innen und Institutionen

  • Department of Cardiology, Copenhagen University Hospital - Herlev & Gentofte, Copenhagen, Denmark.
  • Cardiovascular Medicine Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
  • Cardiovascular Division, Department of Medicine, Women's College Hospital, Toronto, ONT, Canada.
  • Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

Zitieren

APA

Modin, D., Lassen, M. C. H., Claggett, B., Johansen, N. D., Keshtkar-Jahromi, M., Skaarup, K. G., Nealon, J., Udell, J. A., Vardeny, O., Solomon, S. D., Gislason, G., & Biering-Sørensen, T. (2023). Influenza Vaccination and Cardiovascular Events in Patients with Ischaemic Heart Disease and Heart Failure: A Meta-Analysis. European Journal of Heart Failure, 25(9), 1685-1692. https://doi.org/10.1002/ejhf.2945

Vancouver

Modin D, Lassen MCH, Claggett B, Johansen ND, Keshtkar-Jahromi M, Skaarup KG, et al. Influenza Vaccination and Cardiovascular Events in Patients with Ischaemic Heart Disease and Heart Failure: A Meta-Analysis. European Journal of Heart Failure. 2023;25(9):1685-1692. doi:10.1002/ejhf.2945

BibTeX
@article{Modin2023,
  author = {Modin, Daniel and Lassen, Mats Christian Højbjerg and Claggett, Brian and Johansen, Niklas Dyrby and Keshtkar-Jahromi, Maryam and Skaarup, Kristoffer Grundtvig and Nealon, Joshua and Udell, Jacob A and Vardeny, Orly and Solomon, Scott D and Gislason, Gunnar and Biering-Sørensen, Tor},
  title = {Influenza Vaccination and Cardiovascular Events in Patients with Ischaemic Heart Disease and Heart Failure: A Meta-Analysis},
  journal = {European Journal of Heart Failure},
  year = {2023},
  volume = {25},
  number = {9},
  pages = {1685--1692},
  doi = {10.1002/ejhf.2945}
}
Kostenlos starten →